Beta

PARTNERSHIP LEVERAGES IPSC-BASED BETA CELLS FROM EVOTEC’S QRBETA INITIATIVE COMBINED WITH SERNOVA’S PROPRIETARY IMPLANTABLE CELL POUCH™ DEVICE THE GOAL IS THE DEVELOPMENT AND COMMERCIALISATION OF AN OFF-THE-SHELF BETA CELL REPLACEMENT THERAPY FOR INSULIN-DEPENDENT DIABETES EVOTEC MAKES STRATEGIC € 20 M EQUITY INVESTMENT IN SERNOVA EVOTEC/SERNOVA JOINT CONFERENCE CALL AND WEBCAST […]